2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Pathologic Complete Response
1
Adenocarcinoma
1
Interventions
pembrolizumab
1285
Specimen Handling
928
Carboplatin
837
Magnetic Resonance Spectroscopy
834
Cyclophosphamide
808
Cisplatin
736
Nivolumab
681
Paclitaxel
635
Radiotherapy
618
Gemcitabine
580
Biopsy
560
Bevacizumab
486
Dexamethasone
444
fludarabine
410
Docetaxel
385
venetoclax
372
Oxaliplatin
367
Capecitabine
363
Fluorouracil
358
atezolizumab
353
durvalumab
340
Rituximab
336
Drug Therapy
334
Radiosurgery
321
Doxorubicin
320
Blood Specimen Collection
317
Standard of Care
311
Pemetrexed
308
Ipilimumab
303
Radiation
289
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
tegafur-gimeracil-oteracil
×
1 year
×
Clear all
NCT07472868
2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3
Not yet recruiting
394 enrolled
NCT05161572
2025-06-18
NeoRacing
Fudan University
Phase 2
Terminated
6 enrolled